Author:
Yu Dahai,Chen Tao,Cai Yamei,Zhao Zhanzheng,Simmons David
Funder
the International Diabetes Institute
the University of Melbourne
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A8, Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.
2. Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM, Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383(9931):1831–43.
3. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007–2012. Am J Kidney Dis. 2016;S0272–6386(16):30015–4.
4. Yu D, Chen T, Qin R, Cai Y, Jiang Z, Zhao Z, Simmons D. Association between lung capacity and abnormal glucose metabolism: findings from China and Australia. Clin Endocrinol. 2016;85(1):37–45.
5. Yu D, Simmons D. Association between lung capacity measurements and abnormal glucose metabolism: findings from the Crossroads study. Diabet Med. 2014;31(5):595–9.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献